Related Experiment Videos
[Diabetes mellitus, left ventricular dysfunction and congestive heart failure]
Luigi Tarantini1, Andrea Di Lenarda, Mario Velussi
1Divisione di Cardiologia, Ospedale San Martino, Belluno. gitarant@yahoo.com
Summary
Diabetic patients have a higher risk of heart failure due to diabetic cardiomyopathy. Early screening and treatment, including glycemic control and medications, can prevent cardiovascular events.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Diseases
Context:
- Diabetes significantly increases the risk of congestive heart failure.
- Diabetic patients exhibit a 2-fold higher prevalence of left ventricular systolic dysfunction and even more frequent diastolic dysfunction compared to non-diabetics.
- Underlying diabetic cardiomyopathy, hypertension, and ischemic heart disease contribute to the high prevalence of heart dysfunction in diabetics.
Purpose:
- To highlight the increased risk and prevalence of cardiac dysfunction in diabetic patients.
- To emphasize the asymptomatic progression of myocardial damage to heart failure.
- To advocate for early screening and intervention strategies in at-risk diabetic populations.
Summary:
- Diabetic metabolic derangements and sympathetic nervous system activation impair myocardial function, while renin-angiotensin system activation promotes adverse cardiac remodeling.
- Heart failure in diabetic patients often progresses asymptomatically, leading to delayed diagnosis and treatment.
- Echocardiography and cardiac natriuretic peptides may aid in early detection of myocardial damage.
Impact:
- Diabetic patients with heart failure face a worse prognosis.
- Pharmacological treatments (ACE-inhibitors, beta-blockers, ARBs) combined with tight glycemic control can reverse remodeling and prevent cardiovascular events.
- Implementing screening strategies is crucial for early diagnosis and treatment of myocardial damage in diabetic patients, preventing progression to overt heart failure.